Want to see IN:KIMS full AI Analyst Report?
KIMS Stock Chart & Stats
₹653.00
₹11.55(1.78%)
At close: 4:00 PM EST
₹653.00
₹11.55(1.78%)
Day’s Range― - ―
52-Week Range₹575.55 - ₹858.15
Previous CloseN/A
Volume1.26M
Average Volume (3M)23.04K
Market Cap
₹338.59B
Enterprise Value₹360.45B
Total Cash (Recent Filing)₹1.74B
Total Debt (Recent Filing)₹31.87B
Price to Earnings (P/E)133.9
Beta0.76
Next Earnings
Aug 12, 2026EPS Estimate
1.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.39
Shares Outstanding420,006,470
10 Day Avg. Volume26,167
30 Day Avg. Volume23,042
Financial Highlights & Ratios
PEG Ratio-2.77
Price to Book (P/B)11.07
Price to Sales (P/S)6.37
P/FCF Ratio-22.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.03
Revenue Forecast (FY)₹51.33B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent ~3x revenue growth from 2021–2026 indicates durable patient demand and successful expansion of services. That expanding top‑line scale helps absorb fixed hospital costs, supports specialty investments, and provides a stable revenue base to sustain operations and strategy over coming quarters.
Service & Network DiversificationKIMS’s vertically integrated hospital network and broad service set (inpatient, outpatient, diagnostics, pharmacy) creates diversified revenue streams and higher share‑of‑wallet. Tertiary/quaternary capabilities support referral flows and resilience versus single-service providers, strengthening long‑term market positioning.
Asset Growth / Capacity ExpansionSolid asset growth reflects ongoing capacity expansion and reinvestment in infrastructure, enabling higher patient throughput and service breadth. When executed well, expanded assets sustain revenue growth and market presence for multiple quarters, supporting long‑term competitive scale.
Bears Say
Rising LeverageThe sharp rise in leverage to ~1.89 materially increases financial risk and reduces flexibility. Higher interest and refinancing exposure make the company more vulnerable to revenue or margin shocks, limit strategic optionality, and raise the cost of future capital over the medium term.
Negative Free Cash FlowPersistently negative free cash flow (≈-11.15B in 2026) shows operations plus capex are not yet cash‑generative. This elevates reliance on external funding, increases liquidity and execution risk, and may force slower investment or higher leverage if operating cash conversion doesn’t improve over coming quarters.
Profitability CompressionMeaningful margin deterioration—gross and net margins compressed significantly in 2026—signals cost pressures or weaker realizations. Lower margins reduce the ability to self‑fund growth, weaken returns on expanding assets (ROE fell), and increase sensitivity to volume downturns over the medium term.
Krishna Institute of Medical Sciences Limited News
KIMS FAQ
What was Krishna Institute of Medical Sciences Limited’s price range in the past 12 months?
Krishna Institute of Medical Sciences Limited lowest stock price was ₹575.55 and its highest was ₹858.15 in the past 12 months.
What is Krishna Institute of Medical Sciences Limited’s market cap?
Krishna Institute of Medical Sciences Limited’s market cap is ₹338.59B.
When is Krishna Institute of Medical Sciences Limited’s upcoming earnings report date?
Krishna Institute of Medical Sciences Limited’s upcoming earnings report date is Aug 12, 2026 which is in 34 days.
How were Krishna Institute of Medical Sciences Limited’s earnings last quarter?
Krishna Institute of Medical Sciences Limited released its earnings results on May 15, 2026. The company reported ₹1.15 earnings per share for the quarter, missing the consensus estimate of ₹1.528 by -₹0.378.
Is Krishna Institute of Medical Sciences Limited overvalued?
According to Wall Street analysts Krishna Institute of Medical Sciences Limited’s price is currently Overvalued.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited does not currently pay dividends.
What is Krishna Institute of Medical Sciences Limited’s EPS estimate?
Krishna Institute of Medical Sciences Limited’s EPS estimate is 1.48.
How many shares outstanding does Krishna Institute of Medical Sciences Limited have?
Krishna Institute of Medical Sciences Limited has 420,006,470 shares outstanding.
What happened to Krishna Institute of Medical Sciences Limited’s price movement after its last earnings report?
Krishna Institute of Medical Sciences Limited reported an EPS of ₹1.15 in its last earnings report, missing expectations of ₹1.528. Following the earnings report the stock price went down -1.767%.
Which hedge fund is a major shareholder of Krishna Institute of Medical Sciences Limited?
Currently, no hedge funds are holding shares in IN:KIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―